JP2016519065A5 - - Google Patents

Download PDF

Info

Publication number
JP2016519065A5
JP2016519065A5 JP2016502113A JP2016502113A JP2016519065A5 JP 2016519065 A5 JP2016519065 A5 JP 2016519065A5 JP 2016502113 A JP2016502113 A JP 2016502113A JP 2016502113 A JP2016502113 A JP 2016502113A JP 2016519065 A5 JP2016519065 A5 JP 2016519065A5
Authority
JP
Japan
Prior art keywords
polypeptide
acid sequence
amino acid
seq
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502113A
Other languages
English (en)
Japanese (ja)
Other versions
JP6654557B2 (ja
JP2016519065A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/026354 external-priority patent/WO2014151736A1/en
Publication of JP2016519065A publication Critical patent/JP2016519065A/ja
Publication of JP2016519065A5 publication Critical patent/JP2016519065A5/ja
Application granted granted Critical
Publication of JP6654557B2 publication Critical patent/JP6654557B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502113A 2013-03-15 2014-03-13 構造的相補性による生物発光の活性化 Active JP6654557B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361791549P 2013-03-15 2013-03-15
US61/791,549 2013-03-15
PCT/US2014/026354 WO2014151736A1 (en) 2013-03-15 2014-03-13 Activation of bioluminescence by structural complementation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020013133A Division JP7280842B2 (ja) 2013-03-15 2020-01-30 構造的相補性による生物発光の活性化

Publications (3)

Publication Number Publication Date
JP2016519065A JP2016519065A (ja) 2016-06-30
JP2016519065A5 true JP2016519065A5 (https=) 2017-04-13
JP6654557B2 JP6654557B2 (ja) 2020-02-26

Family

ID=51581027

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016502113A Active JP6654557B2 (ja) 2013-03-15 2014-03-13 構造的相補性による生物発光の活性化
JP2020013133A Active JP7280842B2 (ja) 2013-03-15 2020-01-30 構造的相補性による生物発光の活性化
JP2023004036A Active JP7532562B2 (ja) 2013-03-15 2023-01-13 構造的相補性による生物発光の活性化
JP2024124929A Active JP7843318B2 (ja) 2013-03-15 2024-07-31 構造的相補性による生物発光の活性化

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020013133A Active JP7280842B2 (ja) 2013-03-15 2020-01-30 構造的相補性による生物発光の活性化
JP2023004036A Active JP7532562B2 (ja) 2013-03-15 2023-01-13 構造的相補性による生物発光の活性化
JP2024124929A Active JP7843318B2 (ja) 2013-03-15 2024-07-31 構造的相補性による生物発光の活性化

Country Status (15)

Country Link
US (11) US9797889B2 (https=)
EP (4) EP4169935A1 (https=)
JP (4) JP6654557B2 (https=)
KR (3) KR102675860B1 (https=)
CN (2) CN117024548A (https=)
AU (3) AU2014236949C1 (https=)
BR (1) BR112015023394B8 (https=)
CA (3) CA3249512A1 (https=)
DK (2) DK2970412T5 (https=)
ES (2) ES2926463T3 (https=)
IL (3) IL286816B (https=)
PL (2) PL3783011T3 (https=)
PT (2) PT2970412T (https=)
SG (2) SG11201507306VA (https=)
WO (1) WO2014151736A1 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201507306VA (en) 2013-03-15 2015-10-29 Promega Corp Activation of bioluminescence by structural complementation
EP4219736A1 (en) * 2014-09-12 2023-08-02 Promega Corporation Internal protein tags
US11365402B2 (en) 2014-09-12 2022-06-21 Promega Corporation Internal protein tags
EP3254113B1 (en) * 2015-02-05 2024-10-09 Promega Corporation Luciferase-based thermal shift assays
US10634680B2 (en) 2016-04-26 2020-04-28 University Of Utah Research Foundation Target-binding activated split reporter systems for analyte detection and related components and methods
WO2018075783A2 (en) * 2016-10-20 2018-04-26 President And Fellows Of Harvard College In vitro and cell based assays for measuring the activity of botulinum neurotoxins
EP3395803A1 (en) 2017-04-28 2018-10-31 Institut Pasteur Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins
US11579149B2 (en) * 2017-11-01 2023-02-14 Queen's University At Kingston Hippo pathway bioluminescent biosensor
PL3759233T4 (pl) * 2018-02-26 2022-10-10 Technische Universiteit Eindhoven Bioczujnik bioluminescencyjny do wykrywania i oznaczania ilościowego biocząsteczek
EP4140991B1 (en) 2018-06-01 2024-05-15 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes
EP3807419A4 (en) * 2018-06-12 2022-09-07 Promega Corporation MULTIPLE LUCIFERASE
US10962538B2 (en) 2018-06-14 2021-03-30 The Trustees Of Columbia University In The City Of New York Assays using arrestin recruitment and unmodified receptors
CN112996923B (zh) 2018-10-03 2025-02-18 普洛麦格公司 用于稳定腔肠素及其类似物和衍生物的组合物和方法
WO2020113036A2 (en) 2018-11-28 2020-06-04 Promega Corporation Reactive peptide labeling
US20200200765A1 (en) 2018-12-04 2020-06-25 Promega Corporation Broad spectrum gpcr binding agents
EP3941195A4 (en) 2019-03-20 2023-03-22 Promega Corporation PHOTOAFFINITY PROBES
BR112021020354A2 (pt) * 2019-04-10 2021-12-14 Promega Corp Composições e métodos para detecção de analito com o uso de bioluminescência
US11360096B2 (en) 2019-05-16 2022-06-14 Duke University Complex BRET technique for measuring biological interactions
CN114450326B (zh) 2019-06-24 2025-02-11 普罗美加公司 用于将生物分子递送到细胞中的改性聚胺聚合物
DE102019127894B4 (de) * 2019-10-16 2022-05-12 Sensor-Instruments Entwicklungs- Und Vertriebs-Gmbh Produktkennzeichnungssystem und verfahren zur kennzeichnung eines produkts
US20230031446A1 (en) * 2019-11-22 2023-02-02 The Regents Of The University Of California Split-enzyme system to detect specific dna in living cells
KR20220121816A (ko) 2019-11-27 2022-09-01 프로메가 코포레이션 다분할 루시퍼라제 펩타이드 및 폴리펩타이드
US12061202B2 (en) 2019-12-10 2024-08-13 Promega Corporation Compositions and methods for bioluminescent detection using multifunctional probes
EP4127148A1 (en) 2020-03-25 2023-02-08 Erasmus University Rotterdam Medical Center Reporter system for radionuclide imaging
US20230257726A1 (en) * 2020-05-11 2023-08-17 Chan Zuckerberg Biohub, Inc. Ace2 compositions and methods
JP7677997B2 (ja) 2020-05-22 2025-05-15 プロメガ コーポレイション キナーゼターゲットエンゲージメントの増強
CN116391129A (zh) 2020-08-28 2023-07-04 普罗美加公司 针对ras蛋白的靶标接合测定法
EP4337646A4 (en) 2021-05-13 2025-05-21 Promega Corporation BIOLUMINESCENT DETECTION OF DNA SYNTHESIS
US20240252689A1 (en) * 2021-05-18 2024-08-01 The Board Of Regents Of The University Of Texas System Poly-adp ribose (par) tracker optimized split-protein reassembly par detection reagents
EP4519426A2 (en) 2022-05-04 2025-03-12 Promega Corporation Split modified dehalogenase variants
US20240060059A1 (en) 2022-05-04 2024-02-22 Promega Corporation Circularly permuted dehalogenase variants
JP2025515181A (ja) 2022-05-04 2025-05-13 プロメガ コーポレイション 伸長表面ループ領域を有する修飾デハロゲナーゼ
WO2023215497A1 (en) 2022-05-04 2023-11-09 Promega Corporation Photoactivatable compounds and uses thereof
WO2024151471A1 (en) * 2023-01-09 2024-07-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services High-throughput assay based on ligand-biased structural dynamics response
EP4700040A1 (en) * 2023-04-21 2026-02-25 Shenzhen Loggene Life Science & Technology Co., Ltd. Peptide and luminescent complex containing same
AU2024265176A1 (en) * 2023-05-04 2025-12-11 Promega Corporation Complementation-based tags and reporters for dual-modality labeling
WO2025064581A1 (en) * 2023-09-18 2025-03-27 The Brigham And Women’S Hospital, Inc. Biosensor platform for the rapid detection of analytes
WO2025158412A1 (en) 2024-01-26 2025-07-31 Biohaven Therapeutics Ltd. BIFUNCTIONAL DEGRADERS OF IgG4 IMMUNOGLOBULINS
WO2026008850A1 (en) 2024-07-04 2026-01-08 Insempra Gmbh Linear nucleic acid templates for high-efficient cell-free protein expression
WO2026008852A2 (en) 2024-07-04 2026-01-08 Insempra Gmbh Optimized media for highly efficient cell-free protein expression systems

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5914095A (en) 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
WO1994009056A1 (en) 1992-10-14 1994-04-28 Sterling Winthrop Inc. Chelating polymers
US5756688A (en) 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
GB9503969D0 (en) 1995-02-28 1995-04-19 Sams Bernard Incrementing mechanism
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US5879739A (en) 1997-02-20 1999-03-09 Tower Semiconductor Ltd. Batch process for forming metal plugs in a dielectric layer of a semiconductor wafer
JP4613441B2 (ja) * 2000-04-26 2011-01-19 チッソ株式会社 新規ルシフェラーゼおよび発光蛋白質
EP1156103B1 (en) 2000-04-26 2010-08-11 Chisso Corporation Oplophorus luciferase
US20040181830A1 (en) 2001-05-07 2004-09-16 Kovalic David K. Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US7008642B1 (en) 2001-02-12 2006-03-07 Advanced Cardiovascular Systems, Inc. Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same
US7195884B2 (en) 2002-07-19 2007-03-27 Promega Corp. Methods and kits for transferases
US20040115814A1 (en) * 2002-09-30 2004-06-17 Protein Design Labs, Inc. Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes
US7237811B1 (en) * 2005-04-20 2007-07-03 Lawrence Barry G Casement window latch assembly
EP1931787A4 (en) 2005-09-30 2010-10-20 Univ Montana State SYSTEM FOR DETECTING PROTEIN-PROTEIN INTERACTIONS
US7601517B2 (en) 2006-01-10 2009-10-13 Stanford University Split protein self complementing fragments, systems, and methods of use thereof
US20130332133A1 (en) 2006-05-11 2013-12-12 Ramot At Tel Aviv University Ltd. Classification of Protein Sequences and Uses of Classified Proteins
US20090075313A1 (en) 2007-05-04 2009-03-19 Stanford University Split protein fragments, split protein systems, methods of making split protein systems, and methods of using split protein systems
EP2210104A4 (en) * 2007-11-01 2011-02-23 Univ Arizona State CELL-FREE PROCEDURE FOR DETECTING PROTEIN-LIGAND INTERACTIONS
JP5554713B2 (ja) * 2007-11-15 2014-07-23 エンドサイト,インク. 接合体を投与する方法
GB2479847B (en) 2009-02-09 2014-02-19 Jnc Corp Coelenterazine analogs and manufacturing method thereof
WO2010119721A1 (ja) 2009-04-17 2010-10-21 独立行政法人産業技術総合研究所 超高輝度で安定な人工生物発光酵素
LT3409764T (lt) 2009-05-01 2020-06-10 Promega Corporation Sintetinės oplophorus liuciferazės su sustiprinta šviesos išeiga
EP4012714A1 (en) 2010-03-23 2022-06-15 Iogenetics, LLC. Bioinformatic processes for determination of peptide binding
BR112013010487B1 (pt) * 2010-11-02 2021-02-02 Promega Corporation compostos de coelenterazina, kit compreendendo ditos compostos e método para detectar luminescência em uma amostra in vitro
US20150125438A1 (en) * 2012-07-20 2015-05-07 Sang Jae Kim Anti-Inflammatory Peptides and Composition Comprising the Same
AU2013359166B2 (en) * 2012-12-12 2019-09-19 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
SG11201507306VA (en) 2013-03-15 2015-10-29 Promega Corp Activation of bioluminescence by structural complementation
EP4219736A1 (en) * 2014-09-12 2023-08-02 Promega Corporation Internal protein tags

Similar Documents

Publication Publication Date Title
JP2016519065A5 (https=)
JP6591511B2 (ja) スプリットインテイン、複合体およびそれらの使用
JP2024054136A5 (https=)
Timmins et al. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4
JP2017533181A5 (https=)
Lürick et al. Multivalent Rab interactions determine tether-mediated membrane fusion
Ling et al. Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance
JP2018502572A5 (https=)
JP2013531477A5 (https=)
Luncsford et al. Coordination of MYH DNA glycosylase and APE1 endonuclease activities via physical interactions
JP2023503653A5 (https=)
Bates et al. ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6-specific nanobody restricts M. tuberculosis growth in macrophages
JP2003500051A5 (https=)
JP5042237B2 (ja) 血小板抗原特異抗体の結合を中和するペプチドアプタマー並びにそれを含む診断及び治療への応用
RU2009112721A (ru) Частицы с расщепленным ядром, предназначенные для презентации чужеродных молекул, прежде всего для применения в вакцинах, и способ их получения
PH12023553282A1 (en) Antibody-nkg2d ligand domain fusion protein
Capella-Pujol et al. Signatures of VH 1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins
Milrad et al. Insights into plastocyanin–cytochrome b6f complex formation: The role of plastocyanin phosphorylation
RU2011103168A (ru) Функционализированные полипептиды
Gan et al. Two different conformations in hepatitis C virus p7 protein account for proton transport and dye release
CN102186976A (zh) 修饰型生物素结合蛋白
Takeda et al. CP5 system, for simple and highly efficient protein purification with a C-terminal designed mini tag
Diaz et al. The binding of plasmodium falciparum adhesins and erythrocyte invasion proteins to aldolase is enhanced by phosphorylation
PH12023553215A1 (en) Antibody-nkg2d ligand domain fusion protein
JP2022528270A5 (https=)